Table of Contents:
I. NOT-DA-18-017 NIDA to Highlight Topics of Special and/or Continuing Interest in Addiction Research on the NIDA Website. https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-017.html
II. PAR-18-789 Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAR-18-789.html
III. PAS-18-624 Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAS-18-624.html
NOT-DA-18-017 NIDA to Highlight Topics of Special and/or Continuing Interest in Addiction Research on the NIDA Website. https://grants.nih.gov/grants/guide/notice-files/NOT-DA-18-017.html
NIDA is working to reduce the number of specialized Program Announcements (PA) published in the NIH Guide for Grants and Contracts to streamline the application process for our applicant community. Rather than navigating a large number of specialized PAs, NIDA created a website (https://www.drugabuse.gov/funding/funding-priorities/nida-topics-specialcontinuing-interest-dat ) detailing the areas of science with the highest priority for NIDA that leverage parent FOAs to solicit topic-specific applications in these areas. This website will provide information to the research community all in one location. The NIDA Topics of Interests (DAT) site provides links to detailed descriptions of the scientific/research topics of interest, contact information for NIDA program staff with relevant expertise, as well as list of the most relevant parent FOAs that can be used to submit applications in these areas of interest.
NIDA will continue to publish Requests for Applications (RFAs) and Program Announcements as needed to accommodate special receipt dates or review considerations.
---
II. PAR-18-789 Genetic analysis of non-human animal models to understand the genomic architecture of substance use disorders and addictive behaviors (U01 Clinical Trial Not Allowed) https://grants.nih.gov/grants/guide/pa-files/PAR-18-789.html
Application due dates: August 21, 2018, March 19, 2019; August 21, 2019, March 19, 2020; August 21, 2020, March 19, 2021, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Purpose:
The goals of this initiative are to discover allelic variants, genomic alterations, and functional changes associated with addictive behaviors in non-human animals through systems studies that employ genetic and genomics strategies. We also encourage applications that take genetic and/or genomics approaches to integrate data, delineate gene networks, and uncover the function of known or newly discovered genetic or epigenetic variants.
Investigators examining the phenotype of knockout mice are discouraged from submitting applications to this FOA. Instead, they should submit applications in response PA-17-155 (R01) PA-17-157 (R21) Functional Genetics, Epigenetics, and Non-coding RNAs in Substance Use Disorders.”
This FOA will replace PAR-15-120 "Identification of Genetic and Genomic Variants by Next-Gen Sequencing in Non-human Animal Models (U01)."
-----
III. PAS-18-624 Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional) https://grants.nih.gov/grants/guide/pa-files/PAS-18-624.html
Application due dates: Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Purpose:
This funding opportunity announcement (FOA) invites innovative research to characterize the consequences of psychosocial stress on affective/cognitive functioning and/or pain processing as it relates to opioid use disorder (OUD). This FOA encourages research that elucidates mechanisms of action and determinants of vulnerability and/or resilience by which psychosocial stress influence OUD trajectories. Research using basic or clinical approaches is appropriate.
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309
No comments:
Post a Comment